Zheng Y

Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.

8 papers · ORCID

ArticleLSD

Targeting peripheral 5-HT<sub>2A</sub>R enhances antitumor immunity in colorectal cancer.

Wen Y, Tang L, Duan W +22

Europe PMC2026
ArticleKetamine

Targeting TLR4/PPARα-mediated neuroinflammation in the prefrontal cortex: S-ketamine and S-HNK rapidly alleviate depression-like behaviors.

Zhu Q, Zhou X, Gao H +2

Europe PMC2026
ArticleKetamine

Psychoactive substances: novel molecular insights and therapeutic potential for Alzheimer's disease.

Fu C, Li X, Liu X +16

Europe PMC2025
ArticleKetamine

Esketamine Provides Neuroprotection After Intracerebral Hemorrhage in Mice via the NTF3/PI3K/AKT Pathway.

Niu X, Zheng Y, Wang W +11

Europe PMC2024
ArticleKetamine

CircKat6b Mediates the Antidepressant Effect of Esketamine by Regulating Astrocyte Function.

Hu N, Zheng Y, Liu X +5

Europe PMC2025
ArticleLSD

The versatile binding landscape of the TAAR1 pocket for LSD and other antipsychotic drug molecules.

Jiang K, Zheng Y, Zeng L +6

Europe PMC2024
ArticleKetamine

Effects of esketamine on depression-like behavior and dendritic spine plasticity in the prefrontal cortex neurons of spared nerve injury-induced depressed mice.

Huang B, Li X, Zheng Y +2

Europe PMC2024
ArticleKetamine

Esketamine vs Midazolam in Boosting the Efficacy of Oral Antidepressants for Major Depressive Disorder: A Pilot Randomized Clinical Trial.

Xiao C, Zhou J, Li A +9

Europe PMC2023